Amylin: pancreatic hormone of glucose regulation
Keywords:
amylin, glucose homeostasis, gastric emptying in diabetesAbstract
Type I or late-stage (insulin-deflcient) type II diabetes is characterized by impaired glucose homeostasis that results from the destruction of pancreatic {>cells and subsequent loss of insulin production. ln many patients optimal metabolic control, essential for the prevention of diabetic complications, is diflcult to obtain. Abnormalities of gastric emptying are now recognized contributors to variations in glycemic control.
Amylin is now recognised as the third pancreatic hormone involved in the control of glucose homeostasis. lts actions include the modulation of gastric emptying while diverse other effects are still under discussion. Today, recognition of the fact that the level of this hormone is diminished in diabetic patients, together with know ledge of its actions, leads to a possible new future therapeutic perspective involving the admi nistration of amylin analogues.
Downloads
References
Ellenherg & Rilkin's. Diabetes Mellitus - Theory and Practice, fifth edition, 41-43.
Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KBM. Purification and characterization of a peptide from amyloid
- rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 1987; 87: 8628- 8632.
Magali Ahram. Amyline et pro-insuline dans le diabete nem insulinodépendant. Dossier de Diabetologie 1990; 42: 29-35.
Moyses C, Young A, Kolterman O. Modulation of gastric emp tying as a therapeutic approach to glycaemic control. Diab Med l 996; 13: 534-538.
Hennet WM, Smith DM, Bloom SR. lslet amyloid polypeptide: does it play a pathophysiological role in the development of diabetes? Diab Med 1994; 11: 825-829.
Ludvik B, Lell B, Hartter E, Schnack C, Prager R. Decrease of stimulated amylin release precedes impairment of insuline secretion in type II diabetes. Diabetes 1991; 40: 1615-1619.
Macdonald IA. Physiological regulation of gastric emptying and glucose absorption. Diab Med 1996; 13: 511-513.
Kay Wagoner P, Chen Chen, Jennings F, Worley, Dukes D, and Gerry S. Oxford. Amyline modulares P-cell glucose sensingvia effects on stimulus-secretion coupling. Proc Nauti Acad Sci USA 1993; 90: 9145- 9149.
Atsushi Ogawa, Virginia Harris, Sara K McCorkle, Roger H. Un ger, amylin secretion from the rat pancreas and iL selective loss after streptozotocin treatment. J Clin Invest 1990; 85: 973- 976.
Young AA, Cooper GJS, Cario P, Rink lJ, Wang M. Response to intravenous injection of amylin and glucagon in fasted fed and hypoglicemic rats. AmJ Phisiol 1993; 264: 943-950.
Horowitz M, Fraser R. Disordered gastric motor function in diabetes mellitus. Diabetologia 1994; 37: 543- 551.
Horowitz M, Wishart JM, Jones KL, Hebbard GS. Gastric emp tying in diabetes: an overview. Diab Med 1996; 13: 516- 522.
Phillips WT, Schwarz JG, McMahan CA. Rapid gastric emptying of an oral glucose solution in type 2 diabetic patients. J Nucl Med 1992; 33: 1496-1500.
Nowak TV,Johnson CP, Wood CM, Adams MB, Roza AM, Kalhfleisch JH, el al. Evidence of accelerated gastric emptying in asymptomatic patients with insulin- dependent diabetes. Gastroenterology 1990: 98: A378.
M-F.S-C. Kong, Macdonald LA, Tattersall RB. Gastric emptying in diabetes. Diab Med 1996, 13: 112-119.
Fraser R, Horowitz M, Dent J. Hyperglycaemia stimulates pyloric motility in normal subjects. Gut 1991: 32: 475-578.
Schvarcz E, Palmer M, Aman J, Lindkvist B, Beckman K-W. Hypo glycaemia increases the gastric emptying rate in patients with type l diabetes mellitus. Diab Med 1993; 10: 660-663.
Berne C. Hypoglycaemia and gastric emptying. Diab Med 1996; 13: 528-530.
Additional Files
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna
Open Access
